/주식/LFST
LFST

LFST

USD

LifeStance Health Group Inc. Common Stock

$6.530+0.070 (1.084%)

실시간 가격

Healthcare
Medical Care Facilities
미국

가격 차트

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$6.460

고가

$6.540

저가

$6.390

거래량

0.19M

기업 기본 정보

시가총액

2.5B

산업

Medical Care Facilities

국가

United States

거래 통계

평균 거래량

1.78M

거래소

NMS

통화

USD

52주 범위

저가 $4.64현재가 $6.530고가 $8.61

AI 분석 리포트

마지막 업데이트: 2025년 4월 26일
AI 생성데이터 소스: Yahoo Finance, Bloomberg, SEC

LFST: LifeStance Health Group Inc. Common Stock - What's Happening and What to Watch

Stock Symbol: LFST Generate Date: 2025-04-26 11:18:15

Alright, let's break down what's been going on with LifeStance Health, the folks providing mental health services. We'll look at the recent news, check out the stock's price chart, and see what some predictions are saying.

The Latest Buzz: News You Should Know

The news flow for LFST lately has a pretty clear theme: analysts are starting to pay attention and they seem to like what they see.

  • Back in early April, Canaccord Genuity initiated coverage on the stock. They slapped a "Buy" rating on it and put a price target of $8 out there. That's a positive sign – a big firm saying they think the stock is worth picking up.
  • Just a few days later, Keybanc did something similar. They started coverage too, giving LFST an "Overweight" rating (which is basically a bullish or positive view) and set their price target a bit higher at $9.
  • More recently, the company announced they'll be hosting their first quarter 2025 earnings call on May 7th. This isn't news about performance itself, but it's a heads-up that actual results are coming soon. Earnings calls are always a big deal because they give investors a real look under the hood.

So, the general vibe from the news is positive, driven by analysts initiating coverage with bullish ratings and targets. The upcoming earnings call is the next big event on the horizon.

Checking the Price Tag: What the Chart Shows

Looking at the stock's price action over the last few months tells an interesting story. After trading mostly sideways or slightly up around the $7.80 to $8.20 range through January and February, things took a turn.

Starting in late February and continuing into March, the stock saw a noticeable decline. It dropped from the low $8s down into the $7s, and then further into the $6 range by early April.

Since hitting those lower levels, the price has been bouncing around, mostly between $6.25 and $6.90. It hasn't shown a strong upward trend, but it hasn't kept falling sharply either. It looks more like it's been consolidating or trading sideways in this lower range.

The last recorded price was $6.53. This puts it right in the middle of that recent trading range.

What about the very short-term predictions? An AI model suggests tiny moves for the next couple of days: basically flat today (0.00%), a slight dip tomorrow (-0.10%), and then a small bump the day after (+0.53%). This aligns with the recent sideways action – the AI doesn't see a big jump or drop happening immediately.

Putting It All Together: What Might Be Next?

Here's where we try to connect the dots. We have positive analyst sentiment from earlier in April, but the stock price hasn't really taken off based on that news yet. It's been stuck in a lower range after a previous decline. The AI prediction for the next few days suggests this sideways movement might continue.

However, there are some technical signals (mentioned in the recommendation data) that look potentially bullish in the short term. Things like certain indicators lining up suggest buying pressure might be building. Plus, those analyst price targets of $8 and $9 are significantly higher than the current price.

The upcoming earnings call on May 7th is a key date. Good results could provide the catalyst the stock needs to move closer to those analyst targets. Poor results, of course, could send it lower.

Given the positive analyst views, some potentially bullish technical signs, and the stock trading near recent lows (and close to suggested entry points from some analysis), the situation might lean slightly positive for the near term, especially if the upcoming earnings report is well-received.

  • Potential Entry Idea: If you were considering this stock, the current price around $6.53 is very close to the $6.45 - $6.48 range highlighted in some analysis as a potential entry point. This area seems to have offered some support recently.
  • Managing Risk: If you decide to jump in, having a plan is smart. A potential stop-loss level to consider, based on the analysis, is around $5.83. This is below recent lows and could help limit potential losses if the stock unexpectedly drops.
  • Potential Target: On the upside, the analysis points to $6.87 as a potential short-term target (take profit level). This is within the recent trading range but represents a move towards the higher end. The analyst targets of $8 and $9 are longer-term possibilities if the company performs well.

A Little Context

Remember, LifeStance Health is a major provider of outpatient mental health care. This is a sector with growing demand. Their business relies on providing services both in person and online. The upcoming earnings report will give us a better idea of how well they are executing and growing in this space. The fundamental picture also shows some challenges like debt and lower-than-desired profitability metrics, which are important to keep in mind alongside the positive analyst views and technical signals.

Important Disclaimer: This analysis is based only on the provided data and is for informational purposes only. It is not financial advice. Stock markets are risky, and prices can go down as well as up. You should always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

관련 뉴스

GlobeNewswire

LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025

SCOTTSDALE, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter 2025 earnings

더 보기
LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025
Analyst Upgrades

Keybanc Initiates Coverage On LifeStance Health Gr with Overweight Rating, Announces Price Target of $9

Keybanc analyst Steve Dechert initiates coverage on LifeStance Health Gr with a Overweight rating and announces Price Target of $9.

더 보기
Keybanc Initiates Coverage On LifeStance Health Gr with Overweight Rating, Announces Price Target of $9
Analyst Upgrades

Canaccord Genuity Initiates Coverage On LifeStance Health Gr with Buy Rating, Announces Price Target of $8

Canaccord Genuity analyst Richard Close initiates coverage on LifeStance Health Gr with a Buy rating and announces Price Target of $8.

더 보기
Canaccord Genuity Initiates Coverage On LifeStance Health Gr with Buy Rating, Announces Price Target of $8

AI 예측Beta

AI 추천

강세

업데이트 시간: 2025년 4월 28일 오전 07:19

약세중립강세

60.0% 신뢰도

리스크 & 트레이딩

리스크 수준3/5
중위험
적합 대상
가치
트레이딩 가이드

진입점

$6.50

익절

$6.92

손절

$5.88

핵심 요소

PDI 8.8이(가) ADX 17.7과 함께 MDI 5.9 위에 있어 강세 추세를 시사합니다.
현재 가격이 지지선($6.52)에 매우 근접하여 강력한 매수 기회를 시사합니다.
거래량은 평균(21,965)의 3.8배로 극도로 강력한 매수 압력을 나타냅니다.
MACD 0.0072이(가) 신호선 0.0077 아래에 있어 약세 교차를 나타냅니다.

최신 정보 받기

가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기